arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Sunshine Biopharma Inc.

SBFM

$1.24 ▼ -0.16 (-11.43%) at close

17 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Sunshine Biopharma Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.2M

Dividend Yield —

Revenue Growth 4.1% ↘

Op. Margin -17.2% ↘

ROIC -27.1% ↘

FCF / Share $-1.32 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$36.31M

↑ +4.1% —

Net Income Profit after all expenses

$-5.98M

↓ -16.4% —

Operating Margin Operating profit as % of sales

-17.2%

↓ -2.9% 11th

FCF / Share Free cash flow per share

$-1.32

↑ +93.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Revenue Growth YoY (%)	4.1% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-49%)	44.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+459%)	454.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5580%)	1802.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+22430%)	219.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2648%)	238.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2876%)	—	—	—	N/M	—	—	—	—	—	—	—
EPS Growth YoY (%)	80.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3752.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	89.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-74.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1720.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	78.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3450.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-300.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-16.4% Weak ↓ Weak Declining Year-over-year change in net income	-13.9% Weak ↑ Weak Improving Year-over-year change in net income	83.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-115.0% Weak ↑ Weak Improving Year-over-year change in net income	-346.7% Weak ↓ Weak Declining Year-over-year change in net income	-67.7% Weak ↓ Weak Declining Year-over-year change in net income	23.0% Good ↑ Good Improving Year-over-year change in net income	-107.3% Weak ↓ Weak Declining Year-over-year change in net income	70.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-111.5% Weak ↓ Weak Declining Year-over-year change in net income	14.5% Fair ↑ Fair Improving Year-over-year change in net income	22.4% Good ↑ Good Improving Year-over-year change in net income	-251.9% Weak ↓ Weak Declining Year-over-year change in net income	-27.3% Weak Weak Year-over-year change in net income	-3.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	93.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-5451.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	-1.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	48.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-8.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	-1320.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	74.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-1291.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	-1577.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	89.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	12.4% Fair ↑ Fair Improving Year-over-year change in free cash flow	20.1% Good ↑ Good Improving Year-over-year change in free cash flow	-29.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	18.0% Good Good Year-over-year change in free cash flow	17.5% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	102.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	434.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	596.2% Excellent Excellent Compound annual revenue growth over 3 years	490.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	247.7% Excellent Excellent Compound annual revenue growth over 5 years	340.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	111.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Operating Margin (%) (%)	-17.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-214%)	-16.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-211%)	-19.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-232%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-9.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-16.5% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-237%)	-14.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-223%)	-18.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-256%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-15.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-40.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-36.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-125.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.97x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Return on Invested Capital (%)	-27.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-125.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-910.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	47.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	68.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1649.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	118.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	374.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	103.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	357.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19837.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-792.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-426.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-20.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-92.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-110.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-653.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-101.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-332.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1542.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1223.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6197.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-524.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-522.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-25.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-273%)	-21.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-123.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-924%)	—	291.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1844%)	225.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1405%)	—	181.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1110%)	—	276.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1746%)	—	—	—	—	-273.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1926%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Interest Coverage (x)	—	-715.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-34.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-685.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.18x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.46x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-299.93x Weak Weak Operating income divided by interest expense Optimal: > 5x	-555.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	—	—	—	—	$-2.05M	$-989.89K	$-40.50K	$-110.53K	$-107.53K	$-57.45K	$-50.80K	$-143.42K	$-31.24K	$-132.64K	$-60.69K	$-162.39K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Revenue per Share (USD)	$8.73	$49.70	$0.99	$0.29	$0.09	$0.07	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	—
Basic EPS, GAAP (USD)	$-1.44	$-7.32	$-0.19	$-1.76	$-4.76	$-2.73	$-0.15	$-0.71	$-0.02	$-0.01	$-0.01	$-0.03	$-0.04	$-0.01	$-0.02	$-0.02	—
Free Cash Flow per Share (USD)	$-1.32	$-20.21	$-0.36	$-0.36	$-0.70	$-0.65	$-0.05	$-0.17	$-0.01	$-0.00	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	—
Book Value per Share (USD)	$4.70	$9.11	$0.76	$0.96	$0.08	$-0.55	$-0.02	$-0.01	$-0.01	$-0.00	$-0.00	$-0.01	$-0.00	$0.00	$0.00	$0.01	—
Tangible Book Value per Share (USD)	$4.31	$7.94	$0.71	$0.92	$0.08	$-0.55	$-0.04	$-0.17	$-0.01	$-0.00	$-0.00	$-0.01	$-0.00	$0.00	$0.00	$0.01	—
Basic Weighted Avg Shares (shares)	4.16M	701,749	24.33M	15.18M	2.61M	1.02M	10.93M	3.05M	43.63M	424.87M	122.28M	66.13M	55.40M	49.78M	30.88M	29.86M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Working Capital (USD)	$20.41M	$19.65M	$19.34M	$20.38M	$2.10M	$-25.36K	$-767.84K	$188.97K	$-633.94K	$-215.64K	$-1.22M	$-387.58K	—	—	—	—	—
Total Equity (USD)	$23.04M	$23.50M	$21.21M	$21.63M	$211.66K	$-954.84K	$-735.38K	$-55.75K	$-573.36K	$-209.70K	$-597.04K	$-387.58K	$-7.71K	$70.43K	$103.00K	$196.22K	$336.11K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$36.31M	$34.87M	$24.09M	$4.35M	$228.43K	$71.41K	$21.12K	$0.00	$0.00	$0.00	$1.71K	$0.00	$0.00	$0.00	—	$0.00	—
Depreciation Expense (USD)	$332.07K	$223.53K	$110.70K	$20.64K	$12.74K	$14.07K	—	—	—	—	$479.00	$0.00	—	—	—	—	—
Net Income, GAAP (USD)	$-5.98M	$-5.13M	$-4.51M	$-26.74M	$-12.44M	$-2.78M	$-1.66M	$-2.16M	$-1.04M	$-3.50M	$-1.65M	$-1.93M	$-2.49M	$-707.95K	$-556.20K	$-537.38K	—
Operating Cash Flow (USD)	$-5.33M	$-12.52M	$-8.78M	$-5.25M	$-1.83M	$-657.30K	$-495.80K	$-512.81K	$-543.52K	$-314.18K	$-867.64K	$-538.60K	$-564.40K	$-393.05K	$-297.30K	$-348.32K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters

Sunshine Biopharma Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SBFM with peers